Microbiology

  1. Genomic Modeling as an Approach to Identify Surrogates for Use in Experimental Validation of SARS-CoV-2 and HuNoV Inactivation by UV-C Treatment

    1. Brahmaiah Pendyala
    2. Ankit Patras
    3. Bharat Pokharel
    4. Doris D’Souza

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection

    1. Carina Conzelmann
    2. Andrea Gilg
    3. Rüdiger Groß
    4. Desiree Schütz
    5. Nico Preising
    6. Ludger Ständker
    7. Bernd Jahrsdörfer
    8. Hubert Schrezenmeier
    9. Konstantin M.J. Sparrer
    10. Thomas Stamminger
    11. Steffen Stenger
    12. Jan Münch
    13. Janis A. Müller

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity

    1. Seiya Ozono
    2. Yanzhao Zhang
    3. Hirotaka Ode
    4. Kaori Sano
    5. Toong Seng Tan
    6. Kazuo Imai
    7. Kazuyasu Miyoshi
    8. Satoshi Kishigami
    9. Takamasa Ueno
    10. Yasumasa Iwatani
    11. Tadaki Suzuki
    12. Kenzo Tokunaga

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Microscopy‐based assay for semi‐quantitative detection of SARS‐CoV‐2 specific antibodies in human sera

    1. Constantin Pape
    2. Roman Remme
    3. Adrian Wolny
    4. Sylvia Olberg
    5. Steffen Wolf
    6. Lorenzo Cerrone
    7. Mirko Cortese
    8. Severina Klaus
    9. Bojana Lucic
    10. Stephanie Ullrich
    11. Maria Anders‐Össwein
    12. Stefanie Wolf
    13. Berati Cerikan
    14. Christopher J. Neufeldt
    15. Markus Ganter
    16. Paul Schnitzler
    17. Uta Merle
    18. Marina Lusic
    19. Steeve Boulant
    20. Megan Stanifer
    21. Ralf Bartenschlager
    22. Fred A. Hamprecht
    23. Anna Kreshuk
    24. Christian Tischer
    25. Hans‐Georg Kräusslich
    26. Barbara Müller
    27. Vibor Laketa

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. SARS-CoV-2 Neutralizing Antibody Responses Are More Robust in Patients with Severe Disease

    1. Pengfei Wang
    2. Lihong Liu
    3. Manoj S. Nair
    4. Michael T. Yin
    5. Yang Luo
    6. Qian Wang
    7. Ting Yuan
    8. Kanako Mori
    9. Axel Guzman Solis
    10. Masahiro Yamashita
    11. Lawrence J. Purpura
    12. Justin C. Laracy
    13. Jian Yu
    14. Joseph Sodroski
    15. Yaoxing Huang
    16. David D. Ho

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Receptor utilization of angiotensin‐converting enzyme 2 (ACE2) indicates a narrower host range of SARS‐CoV‐2 than that of SARS‐CoV

    1. Qiong Wang
    2. Ye Qiu
    3. Jin‐Yan Li
    4. Ce‐Heng Liao
    5. Zhi‐Jian Zhou
    6. Xing‐Yi Ge

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient

    1. Daming Zhou
    2. Helen M. E. Duyvesteyn
    3. Cheng-Pin Chen
    4. Chung-Guei Huang
    5. Ting-Hua Chen
    6. Shin-Ru Shih
    7. Yi-Chun Lin
    8. Chien-Yu Cheng
    9. Shu-Hsing Cheng
    10. Yhu-Chering Huang
    11. Tzou-Yien Lin
    12. Che Ma
    13. Jiandong Huo
    14. Loic Carrique
    15. Tomas Malinauskas
    16. Reinis R. Ruza
    17. Pranav N. M. Shah
    18. Tiong Kit Tan
    19. Pramila Rijal
    20. Robert F. Donat
    21. Kerry Godwin
    22. Karen R. Buttigieg
    23. Julia A. Tree
    24. Julika Radecke
    25. Neil G. Paterson
    26. Piyada Supasa
    27. Juthathip Mongkolsapaya
    28. Gavin R. Screaton
    29. Miles W. Carroll
    30. Javier Gilbert-Jaramillo
    31. Michael L. Knight
    32. William James
    33. Raymond J. Owens
    34. James H. Naismith
    35. Alain R. Townsend
    36. Elizabeth E. Fry
    37. Yuguang Zhao
    38. Jingshan Ren
    39. David I. Stuart
    40. Kuan-Ying A. Huang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Validation and performance of a quantitative IgG assay for the screening of SARS-CoV-2 antibodies

    1. Ana M. Espino
    2. Petraleigh Pantoja
    3. Carlos A. Sariol

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Remdesivir but not famotidine inhibits SARS-CoV-2 replication in human pluripotent stem cell-derived intestinal organoids

    1. Jana Krüger
    2. Rüdiger Groß
    3. Carina Conzelmann
    4. Janis A. Müller
    5. Lennart Koepke
    6. Konstantin M. J. Sparrer
    7. Desiree Schütz
    8. Thomas Seufferlein
    9. Thomas F.E. Barth
    10. Steffen Stenger
    11. Sandra Heller
    12. Alexander Kleger
    13. Jan Münch

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

    1. Linlin Bao
    2. Wei Deng
    3. Baoying Huang
    4. Hong Gao
    5. Jiangning Liu
    6. Lili Ren
    7. Qiang Wei
    8. Pin Yu
    9. Yanfeng Xu
    10. Feifei Qi
    11. Yajin Qu
    12. Fengdi Li
    13. Qi Lv
    14. Wenling Wang
    15. Jing Xue
    16. Shuran Gong
    17. Mingya Liu
    18. Guanpeng Wang
    19. Shunyi Wang
    20. Zhiqi Song
    21. Linna Zhao
    22. Peipei Liu
    23. Li Zhao
    24. Fei Ye
    25. Huijuan Wang
    26. Weimin Zhou
    27. Na Zhu
    28. Wei Zhen
    29. Haisheng Yu
    30. Xiaojuan Zhang
    31. Li Guo
    32. Lan Chen
    33. Conghui Wang
    34. Ying Wang
    35. Xinming Wang
    36. Yan Xiao
    37. Qiangming Sun
    38. Hongqi Liu
    39. Fanli Zhu
    40. Chunxia Ma
    41. Lingmei Yan
    42. Mengli Yang
    43. Jun Han
    44. Wenbo Xu
    45. Wenjie Tan
    46. Xiaozhong Peng
    47. Qi Jin
    48. Guizhen Wu
    49. Chuan Qin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 52 of 246 Next